339 related articles for article (PubMed ID: 19359597)
1. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
Lombardi R; Dong J; Rodriguez G; Bell A; Leung TK; Schwartz RJ; Willerson JT; Brugada R; Marian AJ
Circ Res; 2009 May; 104(9):1076-84. PubMed ID: 19359597
[TBL] [Abstract][Full Text] [Related]
2. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.
Garcia-Gras E; Lombardi R; Giocondo MJ; Willerson JT; Schneider MD; Khoury DS; Marian AJ
J Clin Invest; 2006 Jul; 116(7):2012-21. PubMed ID: 16823493
[TBL] [Abstract][Full Text] [Related]
3. Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy.
Lombardi R; da Graca Cabreira-Hansen M; Bell A; Fromm RR; Willerson JT; Marian AJ
Circ Res; 2011 Dec; 109(12):1342-53. PubMed ID: 22021931
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: a disease of cardiac stem cells.
Lombardi R; Marian AJ
Pediatr Cardiol; 2011 Mar; 32(3):360-5. PubMed ID: 21267716
[TBL] [Abstract][Full Text] [Related]
5. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy.
Chen SN; Gurha P; Lombardi R; Ruggiero A; Willerson JT; Marian AJ
Circ Res; 2014 Jan; 114(3):454-68. PubMed ID: 24276085
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene.
Lombardi R; Chen SN; Ruggiero A; Gurha P; Czernuszewicz GZ; Willerson JT; Marian AJ
Circ Res; 2016 Jun; 119(1):41-54. PubMed ID: 27121621
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism.
MacRae CA; Birchmeier W; Thierfelder L
J Clin Invest; 2006 Jul; 116(7):1825-8. PubMed ID: 16823481
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells.
Lombardi R; Marian AJ
Curr Opin Cardiol; 2010 May; 25(3):222-8. PubMed ID: 20124997
[TBL] [Abstract][Full Text] [Related]
9. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.
Sommariva E; Brambilla S; Carbucicchio C; Gambini E; Meraviglia V; Dello Russo A; Farina FM; Casella M; Catto V; Pontone G; Chiesa M; Stadiotti I; Cogliati E; Paolin A; Ouali Alami N; Preziuso C; d'Amati G; Colombo GI; Rossini A; Capogrossi MC; Tondo C; Pompilio G
Eur Heart J; 2016 Jun; 37(23):1835-46. PubMed ID: 26590176
[TBL] [Abstract][Full Text] [Related]
10. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling.
Li J; Swope D; Raess N; Cheng L; Muller EJ; Radice GL
Mol Cell Biol; 2011 Mar; 31(6):1134-44. PubMed ID: 21245375
[TBL] [Abstract][Full Text] [Related]
11. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice.
Kirchhof P; Fabritz L; Zwiener M; Witt H; Schäfers M; Zellerhoff S; Paul M; Athai T; Hiller KH; Baba HA; Breithardt G; Ruiz P; Wichter T; Levkau B
Circulation; 2006 Oct; 114(17):1799-806. PubMed ID: 17030684
[TBL] [Abstract][Full Text] [Related]
12. A novel murine model for arrhythmogenic cardiomyopathy points to a pathogenic role of Wnt signalling and miRNA dysregulation.
Calore M; Lorenzon A; Vitiello L; Poloni G; Khan MAF; Beffagna G; Dazzo E; Sacchetto C; Polishchuk R; Sabatelli P; Doliana R; Carnevale D; Lembo G; Bonaldo P; De Windt L; Braghetta P; Rampazzo A
Cardiovasc Res; 2019 Mar; 115(4):739-751. PubMed ID: 30304392
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
[TBL] [Abstract][Full Text] [Related]
14. Loss of plakoglobin immunoreactivity in intercalated discs in arrhythmogenic right ventricular cardiomyopathy: protein mislocalization versus epitope masking.
Kant S; Krusche CA; Gaertner A; Milting H; Leube RE
Cardiovasc Res; 2016 Feb; 109(2):260-71. PubMed ID: 26676851
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity.
Ma Q; Zhou B; Pu WT
Dev Biol; 2008 Nov; 323(1):98-104. PubMed ID: 18775691
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 10 gene regulation in the second heart field by Tbx1, Nkx2-5, and Islet1 reveals a genetic switch for down-regulation in the myocardium.
Watanabe Y; Zaffran S; Kuroiwa A; Higuchi H; Ogura T; Harvey RP; Kelly RG; Buckingham M
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18273-80. PubMed ID: 23093675
[TBL] [Abstract][Full Text] [Related]
17. Molecular changes in the heart of a severe case of arrhythmogenic right ventricular cardiomyopathy caused by a desmoglein-2 null allele.
Gehmlich K; Syrris P; Reimann M; Asimaki A; Ehler E; Evans A; Quarta G; Pantazis A; Saffitz JE; McKenna WJ
Cardiovasc Pathol; 2012; 21(4):275-82. PubMed ID: 22036071
[TBL] [Abstract][Full Text] [Related]
18. Foxh1 is essential for development of the anterior heart field.
von Both I; Silvestri C; Erdemir T; Lickert H; Walls JR; Henkelman RM; Rossant J; Harvey RP; Attisano L; Wrana JL
Dev Cell; 2004 Sep; 7(3):331-45. PubMed ID: 15363409
[TBL] [Abstract][Full Text] [Related]
19. Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model.
Lyon RC; Mezzano V; Wright AT; Pfeiffer E; Chuang J; Banares K; Castaneda A; Ouyang K; Cui L; Contu R; Gu Y; Evans SM; Omens JH; Peterson KL; McCulloch AD; Sheikh F
Hum Mol Genet; 2014 Mar; 23(5):1134-50. PubMed ID: 24108106
[TBL] [Abstract][Full Text] [Related]
20. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
